Trick is finding the ‘budding’ U.S. marijuana stocks and Canadian marijuana stocks that are set to launch
BayStreet.ca | April 27, 2017 | SmallCapPower: Nobody can argue, legal marijuana is a huge growth industry, in every sense of the word. Legal marijuana sales reached $6.9 billion in 2016, and many experts predict that number may triple now that California has voted to legalize recreational use. Bloomberg forecasts that the industry may reach $50 billion in the next 10 years ($22.8 billion by 2020).
Some investors are starting to wonder if there’s a way they can make money in this sector?
Well yes there is, or at least there are stocks they can buy if they want to bet on the industry’s continued growth, which every analyst out there agrees it will.
Many marijuana stocks have already skyrocketed, so the trick is finding the ‘budding’ stocks in this sector that are set to launch, so you can maximize your gains.
While medical and/or recreational marijuana is legal in 28 states and the District of Columbia, it remains illegal under federal laws which were generally not enforced during the Obama administration. One of the biggest risks facing the industry today is that President Donald Trump and Attorney General Jeff Sessions may begin enforcing those laws which could conceivably cause the entire industry to shut down. So while there may a big up side to investing in the legal marijuana industry, you could also lose big depending how things play out. Keep that in mind when deciding whether and how much to invest.
Here are some of cannabis-related stocks we think have solid potential in the very near future:
MYM Nutraceuticals (OTCQB:MYMMF)
MYM Nutraceuticals is a bio-pharmaceutical company focused on production, distribution, innovation, technology and branded products related to the marijuana industry. It’s a unique formula of natural, medicinal solutions supported by integrated operations.
MYM Nutraceuticals (MYMMF) is a well-positioned company in the marijuana space taking an integrated approach with a long-term perspective. The company is a serious contender with current operations, experienced medical management and a host of early successes that put its stock on track for major gains.
MYM is based in Canada, where legislation is guaranteed under Government by 2018, and has expansion underway in the USA with their CBD line, Hempmed. They recently listed their shares on the OTCQB. Taking into consideration the coming legislation in Canada, the Growth in the USA and the new trading listing in the states, your timing is bang-on to pick some MYMMF up and watch it grow.
For more information on MYM Nutraceuticals, review this research report by clicking here
Medicine Man Technologies Inc. (OTCQB:MDCL)
Medicine Man Technologies is a consulting and licensing services company that serves cultivators, dispensaries, vendors, and investors. Its co-founder also co-founded Colorado’s largest marijuana cultivator and retailer. Medicine Man Technologies has a market cap of only $18 million, and it lost about 2 cents per share last fiscal year. But sales have been growing at a rapid clip, and the company may have real potential.
AbbVie (NYSE: ABBV)
AbbVie was spun off from Abbott Labs in 2013 as a biopharmaceutical firm. It has 28,000 employees. Although it’s not cannabis-focused, the company already has one cannabis-based drug, called Marinol, approved by the FDA. AbbVie has a market cap of $101.7 billion, a price to earnings (P/E) ration of 16.8, and earnings per share (EPS) of $3.65 as of the end of 2016. In February, it announced a stock buyback.
[Editor’s Note: Here’s some Canadian marijuana stocks that show promise for 2017:
Aphria Inc. (TSX: APH) – Our analyst, in his latest report, calls Aphria one of the safest bets in the space, as the Company is profitable, cash-flow positive, and their expansions are phased so construction and Capex can be adjusted to meet changes in legislative timelines, reducing the potential for a large loss.
Aurora Cannabis Inc. (TSXV: ACB) – Aurora’s new Aurora Sky facility prototype would result in a slightly smaller facility (approximately 800,000 square feet), boasting production efficiencies of nearly double those of Aphria or Canopy, which should result in cost reductions, potentially making Aurora the most profitable player in the Canadian space. Aurora Cannabis is seen by many as having the best-quality product on the market.
WeedMD Inc. (TSXV: WMD) – Canada’s newest marijuana stock is licensed under the Access to Cannabis for Medical Purposes Regulations to cultivate marijuana seeds and plants and dried marijuana product from its 26,000 sq. ft. facilities located at the former Imperial Tobacco plant in Aylmer, Ontario, a two-hour drive from Toronto. WeedMD plans to become Canada’s first producer focused on the long-term and retirement sector by leveraging the Company’s deep industry relationships and expertise. Its management team believes senior patients represent a significantly higher value market segment than typical ACMPR patients, due in large part to consistent treatment schedules and the cost-effective nature of patient acquisition and servicing associated with long-term care facilities. (Read more here)]
Read more at baystreet.ca
Disclosure: Neither any of the principals at Small Cap Power, nor their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
